JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

JAZZ - Jazz Pharmaceuticals PLC

USD|NASDAQ|Healthcare

JAZZ Financials - Jazz Pharmaceuticals Income & Cash Flow | Ledgeburg

Financials of JAZZ

Revenue$4.267586B

Operating Income$-430.24M

Net Income$-356.148M

Share Count (Basic)60.981M

Operating Cash Flow$1.355773B

Free Cash Flow$1.297021B

Cash And Short-Term Equivalents$1.391899B

Total Debt$5.358257B

AnnualQuarterly

Revenue $USD

01B2B3B4B

FY2021FY2022FY2023FY2024FY2025

AnnualQuarterly

Net Income $USD

-400M-200M0200M400M600M

AnnualQuarterly

Margins

GrossOperatingNet

-10%0%10%